Compliance & Validation — Documented
SOC 2 Type II, ISO 27001, 21 CFR Part 11, GDPR
Cloud R&D platform for life sciences combining electronic lab notebook, sample tracking, and scientific workflow tools.
Benchling, founded in 2012 and headquartered in San Francisco, provides a cloud platform for life sciences R&D that combines an electronic lab notebook, LIMS-style sample tracking, and workflow tools used by biotech and pharma research teams. The company maintains ISO/IEC 27001 certification and SOC 2 Type II attestation, and documents how the platform is built for compliance with FDA 21 CFR Part 11 and Annex 11 for use in regulated (GxP) environments.
57% — Partial coverage. Coverage score — how completely Atlas documents Benchling across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
SOC 2 Type II, ISO 27001, 21 CFR Part 11, GDPR
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, Large Pharma, Top 20 Pharma, Academic / Research, Drug Discovery, R&D Leadership, Data Management, IT / Digital
Data & AI Infrastructure
Series F, $412M raised, Founded 2012
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?